Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP)
Multicenter Randomized Open-labelled Trial Which Aims to Show Non-inferiority of Adverse Events Risk During the Maintenance of Oral-anticoagulation in the Surgery of Benign Prostatic Hypertrophy by Laser Photovaporization
Sponsor: Boston Scientific Corporation
Listed as NCT03297281, this NA trial focuses on Anticoagulant Adverse Reaction and Benign Prostatic Hyperplasia and remains actively recruiting participants. Sponsored by Boston Scientific Corporation, it has been updated 15 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Mar 2026 — Present [monthly]
Recruiting NA
-
Jul 2025 — Mar 2026 [monthly]
Recruiting NA
-
Sep 2024 — Jul 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Feb 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 10 earlier versions
-
Nov 2022 — Feb 2024 [monthly]
Recruiting NA
-
Apr 2022 — Nov 2022 [monthly]
Recruiting NA
-
Feb 2021 — Apr 2022 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
-
Nov 2019 — Feb 2020 [monthly]
Recruiting NA
-
Mar 2019 — Nov 2019 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Scientific Corporation
- Clinique Pasteur
- Iqvia Pty Ltd
For direct contact, visit the study record on ClinicalTrials.gov .